Automated sputum cytometry for detection of intraepithelial neoplasias in the lung

Analytical Cellular Pathology

Volumn 35, Issue 3, 2012, Pages 187-201

  Li, Gerald ^a   Guillaud, Martial ^a   Leriche, Jean ^a   McWilliams, Annette ^a   Gazdar, Adi ^b   Lam, Stephen ^a   MacAulay, Calum ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Biomarkers and intervention; Biomarkers and intervention studies; Cancer surveillance and screening; Chemoprevention; Intermediate or pre neoplastic markers and risk factors; Intraepithelial neoplasia (IEN); Lung cancer; Risk assessment

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CARCINOMA IN SITU; CHEMOPROPHYLAXIS; DYSPLASIA; FEMALE; FEULGEN STAINING; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LUNG TUMOR; MALE; ONCOGENESIS AND MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RISK FACTOR; SMOKING HABIT; SPUTUM CYTODIAGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; AUTOMATION; BRONCHI; CARCINOMA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMAGE CYTOMETRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; RESPIRATORY MUCOSA; SPUTUM;

EID: 84859976811     PISSN: 22107177     EISSN: 22107185     Source Type: Journal    
DOI: 10.1155/2012/289625     Document Type: Article

References (58)

1. E. Brambilla, S. Gazzeri, S. Lantuejoul, J.L. Coll, D. Moro, A. Negoescu and C. Brambilla, p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer, Clin Cancer Res 4 (1998), 1609-1618. (Pubitemid 28304721)
2. R.M. Bremnes, R. Sirera and C. Camps, Circulating tumourderived DNA and RNA markers in blood: A tool for early detection, diagnostics, and follow-up? Lung Cancer 49 (2005), 1-12. (Pubitemid 40798088)
3. D.J. Brenner, Radiation risks potentially associated with lowdose CT screening of adult smokers for lung cancer, Radiology 231 (2004), 440-445. (Pubitemid 38552902)
4. D.C. Brown and K.C. Gatter, Ki67 protein: The immaculate deception? Histopathology 40 (2002), 2-11. (Pubitemid 34107377)
5. A. Cassidy, S.W. Duffy, J.P.Myles, T. Liloglou and J.K. Field, Lung cancer risk prediction: A tool for early detection, Int J Cancer 120 (2007), 1-6. (Pubitemid 44901910)
6. D. Chiu, M. Guillaud, D. Cox, M. Follen and C. MacAulay, Quality assurance system using statistical process control: An implementation for image cytometry, Cell Oncol 26 (2004), 101-117. (Pubitemid 39127823)
7. J.M. Croswell, S.G. Baker, P.M. Marcus, J.D. Clapp and B.S. Kramer, Cumulative incidence of false-positive test results in lung cancer screening:Arandomized trial, Ann Intern Med 152 (2010), 505-512.
8. A. Doudkine, C. MacAulay, N. Poulin and B. Palcic, Nuclear texture measurements in image cytometry, Pathologica 87 (1995), 286-299.
9. E. Edell, S. Lam, H. Pass, Y.E. Miller, T. Sutedja, T. Kennedy, G. Loewen, R.L. Keith and A. Gazdar, Detection and localization of intraepithelial neoplasia and invasive carcinoma using fluorescence-reflectance bronchoscopy: An international, multicenter clinical trial, J Thorac Oncol 4 (2009), 49-54.
10. R.S. Fontana, D.R. Sanderson, L.B.Woolner,W.F.Taylor,W.E. Miller and J.R. Muhm, Lung cancer screening: The Mayo program, J Occup Med 28 (1986), 746-750. (Pubitemid 16055356)
11. D.M. Garner, A. Harrison, C. MacAulay and B. Palcic, Cyto-Savant™ and its use in automated screening of cervical smears, In: G.L. Wied, P.H. Bartels, P.H. Rosenthal and U. Schenck, eds., Compendium on the Computerized Cytology and Histology Laboratory, Tutorials of Cytology, Chicago, 1994, pp. 346-352.
12. J. Gray, J.T. Mao, E. Szabo, M. Kelley, J. Kurie and G. Bepler, Lung cancer chemoprevention: ACCP evidence-based clinical practice guidelines (2nd Edition), Chest 132 (2007), 56S-68S. (Pubitemid 47502799)
13. M. Guillaud, D. Cox, A. Malpica, G. Staerkel, J. Matisic, D. Van Niekirk, K. Adler-Storthz, N. Poulin, M. Follen and C. MacAulay, Quantitative histopathological analysis of cervical intra-epithelial neoplasia sections: Methodological issues, Cell Oncol 26 (2004), 31-43. (Pubitemid 39108241)
14. M. Guillaud, J.C. le Riche, C. Dawe, J. Korbelik, A. Coldman, I.I.Wistuba, I.-W. Park, A. Gazdar, S.Lamand C.E. MacAulay, Nuclear morphometry as a biomarker for bronchial intraepithelial neoplasia: Correlation with genetic damage and cancer development, Cytometry A 63 (2005), 34-40. (Pubitemid 40194277)
15. C.I. Henschke, D.F. Yankelevitz, D.M. Libby, M.W. Pasmantier, J.P. Smith and O.S. Miettinen, Survival of patients with Stage I lung cancer detected on CT screening, N Engl J Med 355 (2006), 1763-1771. (Pubitemid 44631359)
16. F.R. Hirsch, D.T.Merrick andW.A. Franklin, Role of biomarkers for early detection of lung cancer and chemoprevention, Eur Respir J 19 (2002), 1151-1158. (Pubitemid 34649633)
17. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward and D. Forman, Global cancer statistics, CA Cancer J Clin 61 (2011), 69-90.
18. A. Jemal, R. Siegel, J. Xu and E. Ward, Cancer statistics, CA Cancer J Clin 60 (2010), 277-300.
19. R.L. Katz, T.M. Zaidi, R.L. Fernandez, J. Zhang, W. He, C. Acosta, M. Daniely, L. Madi, M.A. Vargas, Q. Dong, X. Gao, F. Jiang, N.P. Caraway, A.A. Vaporciyan, J.A. Roth and M.R. Spitz, Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer, Mod Pathol 21 (2008), 950-960.
20. G.J. Kelloff, S.M. Lippman, A.J. Dannenberg, C.C. Sigman, H.L. Pearce, B.J. Reid, E. Szabo, V.C. Jordan, M.R. Spitz, G.B. Mills, V.A. Papadimitrakopoulou, R. Lotan, B.B. Aggarwal, R.S. Bresalier, J. Kim, B. Arun, K.H. Lu, M.E. Thomas, H.E. Rhodes, M.A. Brewer,M. Follen, D.M. Shin, H.L. Parnes, J.M. Siegfried, A.A. Evans,W.J. Blot,W.H. Chow, P.L. Blount, C.C. Maley, K.K. Wang, S. Lam, J.J. Lee, S.M. Dubinett, P.F. Engstrom, F.L. Meyskens Jr, J. O'Shaughnessy, E.T. Hawk, B. Levin, W.G. Nelson, W.K. Hong, The AACR Task Force on Cancer Prevention and Progress in chemoprevention drug development: The promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer-Aplan tomove forward, Clin Cancer Res 12 (2006), 3661-3697. (Pubitemid 44000248)
21. R.A.Kemp, D.M. Reinders and B.Turic, Detection of lung cancer by automated sputum cytometry, J Thorac Oncol 2 (2007), 993-1000. (Pubitemid 350059574)
22. F.R. Khuri, J.S. Lee, S.M. Lippman, J.J. Lee, S. Kalapurakal, R. Yu, J.Y. Ro, R.C. Morice, W.K. Hong and W.N. Hittelman, Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers, Cancer Epidemiol Biomarkers Prev 10 (2001), 311-318. (Pubitemid 32703214)
23. C. Kiyohara and Y. Ohno, Sex differences in lung cancer susceptibility: A review, Gend Med 7 (2010), 381-401.
24. S. Lam, J.C. leRiche, A. McWilliams, C. MacAulay, Y. Dyachkova, E. Szabo, J. Mayo, R. Schellenberg, A. Coldman, E. Hawk and A. Gazdar, A randomized Phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium, Clin Cancer Res 10 (2004), 6502-6511. (Pubitemid 39346545)
25. S. Lam, C. MacAulay, J.C. leRiche, Y. Dyachkova, A. Coldman, M. Guillaud, E. Hawk, M.-O. Christen and A.F. Gazdar,A randomized Phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia, J Natl Cancer Inst 94 (2002), 1001-1009. (Pubitemid 34814729)
26. S. Lam, A. McWilliams, J. leRiche, C. MacAulay, L. Wattenberg and E. Szabo, A Phase I study of myo-inositol for lung cancer chemoprevention, Cancer Epidemiol Biomarkers Prev 15 (2006), 1526-1531. (Pubitemid 44299327)
27. J.J. Lee, D. Liu, J.S. Lee, J.M. Kurie, F.R. Khuri, H. Ibarguen, R.C. Morice, G. Walsh, J.Y. Ro, A. Broxson, W.K. Hong and W.N. Hittelman, Long-term impact of smoking on lung epithelial proliferation in current and former smokers, J Natl Cancer Inst 93 (2001), 1081-1088. (Pubitemid 32717540)
28. C. MacAulay, Development, implementation and evaluation of segmentation algorithms for the automatic classification of cervical cells, Ph.D. Dissertation, The University of British Columbia, 1989.
29. C. MacAulay, S. Lam, P.W. Payne, J.C. LeRiche and B. Palcic, Malignancy-associated changes in bronchial epithelial cells in biopsy specimens, Anal Quant Cytol Histol 17 (1995), 55-61.
30. A. McWilliams, B. Lam and T. Sutedja, Early proximal lung cancer diagnosis and treatment, Eur Respir J 33 (2009), 656-665.
31. A. McWilliams, C. MacAulay, A.F. Gazdar and S. Lam, Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions, Oncogene 21 (2002), 6949-6959. (Pubitemid 35221940)
32. A.P. Meert, F. Feoli, B. Martin, J.M. Verdebout, C. Mascaux, A. Verhest, V. Ninane and J.P. Sculier, Ki67 expression in bronchial preneoplastic lesions and carcinoma in situ defined according to the new 1999 WHO/IASLC criteria: A preliminary study, Histopathology 44 (2004), 47-53. (Pubitemid 38174870)
33. K. Moghissi, K. Dixon and M.R. Stringer, Current indications and future perspective of fluorescence bronchoscopy:Areview study, Photodiagnosis Photodyn Ther 5 (2008), 238-246.
34. National Lung Screening Trial Research Team, Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med 365 (2011), 395-409.
35. H.E. Nieburgs, Recent progress in the interpretation of malignancy associated changes (MAC), Acta Cytol 12 (1968), 445-453.
36. J.A. O'Shaughnessy, G.J. Kelloff, G.B. Gordon, A.J. Dannenberg, W.K. Hong, C.J. Fabian, C.C. Sigman, M.M. Bertagnolli, S.P. Stratton, S. Lam, W.G. Nelson, F.L. Meyskens, D.S. Alberts, M. Follen, A.K. Rustgi, V. Papadimitrakopoulou, P.T. Scardino, A.F. Gazdar, L.W. Wattenberg, M.B. Sporn, W.A. Sakr, S.M. Lippman and D.D. Von Hoff, Treatment and prevention of intraepithelial neoplasia: An important target for accelerated new agent development, Clin Cancer Res 8 (2002), 314-346.
37. B. Palcic, D.M. Garner, J. Beveridge, X.R. Sun, A. Doudkine, C. MacAulay, S. Lam and P.W. Payne, Increase of sensitivity of sputum cytology using high-resolution image cytometry: Field study results, Cytometry 50 (2002), 168-176. (Pubitemid 37517316)
38. B. Palcic, C. MacAulay, S. Shlien, W. Treurniet, H. Tezcan and G. Anderson, Comparison of three different methods for automated classification of cervical cells, Anal Cell Pathol 4 (1992), 429-441.
39. P.W. Payne, T.J. Sebo, A. Doudkine, D. Garner, C. MacAulay, S. Lam, J.C. LeRiche and B. Palcic, Sputum screening by quantitative microscopy: A reexamination of a portion of the National Cancer Institute Cooperative Early Lung Cancer Study, Mayo Clin Proc 72 (1997), 697-704. (Pubitemid 127758156)
40. H.K. Roy, H. Subramanian, D. Damania, T.A. Hensing, W.N. Rom, H.I. Pass, D. Ray, J.D. Rogers, A. Bogojevic, M. Shah, T. Kuzniar, P. Pradhan and V. Backman, Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: Implications for screening, Cancer Res 70 (2010), 7748-7754.
41. G. Saccomanno, V.E. Archer, O. Auerbach, R.P. Saunders and L.M. Brennan, Development of carcinoma of the lung as reflected in exfoliated cells, Cancer 33 (1974), 256-270.
42. M. Saito, H. Kato, T. Tsuchida and C. Konaka, Chemoprevention effects on bronchial squamous metaplasia by folate and vitamin B12 in heavy smokers, Chest 106 (1994), 496-499. (Pubitemid 24252049)
43. T. Scholzen and J. Gerdes, The Ki-67 protein: From the known and the unknown, J Cell Physiol 182 (2000), 311-322. (Pubitemid 30054364)
44. G. Schreiber and D.C. McCrory, Performance characteristics of different modalities for diagnosis of suspected lung cancer: Summary of published evidence, Chest 123 (2003), 115S-128S. (Pubitemid 36135709)
45. T. Shaipanich, A. McWilliams and S. Lam, Early detection and chemoprevention of lung cancer, Respirology 11 (2006), 366-372. (Pubitemid 43824332)
46. D.P. Slaughter, H.W. Southwick and W. Smejkal, "Field cancerization" in oral stratified squamous epithelium; clinical implications of multicentric origin, Cancer 6 (1953), 963-968.
47. M.R. Spitz, C.J. Etzel, Q. Dong, C.I. Amos, Q. Wei, X. Wu and W.K. Hong, An expanded risk prediction model for lung cancer, Cancer Prev Res (Phila) 1 (2008), 250-254.
48. M.B. Sporn, Chemoprevention of cancer, Lancet 342 (1993), 1211-1213. (Pubitemid 23331714)
49. S.J. Swensen, J.R. Jett, T.E. Hartman, D.E. Midthun, S.J. Mandrekar, S.L. Hillman, A.M. Sykes, G.L. Aughenbaugh, A.O. Bungum and K.L. Allen, CT screening for lung cancer: Fiveyear prospective experience, Radiology 235 (2005), 259-265. (Pubitemid 40432263)
50. P. Szulakowski, A.J. Crowther, L.A. Jimenez, K. Donaldson, R. Mayer,T.B. Leonard,W. MacNee and E.M. Drost, The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med 174 (2006), 41-50. (Pubitemid 43955243)
51. M.C. Tammemagi, S.C. Lam, A.M.McWilliams and D.D. Sin, Incremental value of pulmonary function and sputum DNA image cytometry in lung cancer risk prediction, Cancer Prev Res (Phila) 4 (2011), 552-561.
52. W.D. Travis, T.V. Colby, B. Corrin, Y. Shimosato and E. Brambilla, Histologic and graphical text slides for the histological typing of lung and pleural tumors, In: International histological classification of tumors, 3rd ed.,World Health Organization Pathology Panel, Springer Verlag, Berlin, 1999, p. 5.
53. M.Varella-Garcia, A.P. Schulte, H.J.Wolf,W.J. Feser,C. Zeng, S. Braudrick, X. Yin, F.R. Hirsch, T.C. Kennedy, R.L. Keith, A.E. Baron, S.A. Belinsky, Y.E. Miller, T. Byers and W.A. Franklin, The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence, Cancer Prev Res (Phila) 3 (2010), 447-453.
54. Y.C.Wang, H.S. Hsu, T.P. Chen and J.T. Chen, Molecular diagnostic markers for lung cancer in sputum and plasma, Ann N Y Acad Sci 1075 (2006), 179-184.
55. R.C. Winterhalder, F.R. Hirsch, G.K. Kotantoulas, W.A. Franklin and P.A. Bunn Jr, Chemoprevention of lung cancer-from biology to clinical reality, Ann Oncol 15 (2004), 185-196. (Pubitemid 38262613)
56. S. Xing, B. Khanavkar, J.A. Nakhosteen, Z. Atay, K.-H. J̈ockel, W. Marek and The Research Institute for Diagnosis Treatment of Early Lung Cancer (RIDTELC) Lung Study Group, Predictive value of image cytometry for diagnosis of lung cancer in heavy smokers, Eur Respir J 25 (2005), 956-963. (Pubitemid 40823768)
57. J. Yee, M.D. Sadar, D.D. Sin, M. Kuzyk, L. Xing, J. Kondra, A. McWilliams, S.F. Man and S. Lam, Connective tissueactivating peptide III: A novel blood biomarker for early lung cancer detection, J Clin Oncol 27 (2009), 2787-2792.
58. C.-Q. Zhu,W. Shih, C.-H. Ling and M.-S. Tsao, Immunohistochemical markers of prognosis in non-small cell lung cancer: A review and proposal for a multiphase approach to marker evaluation, J Clin Pathol 59 (2006), 790-800. (Pubitemid 44211740)